1. INTRODUCTION {#sec0005}
===============

The term 'recovery' is widely used within international addictions literature, policy and practice ([@bib0025], [@bib0030], [@bib0110], [@bib0115], [@bib0220], [@bib0240]). Although the concept was once almost exclusively associated with 12-step fellowships and abstinence ([@bib0115]), there is growing recognition that recovery can be supported by appropriately prescribed medications ([@bib0005], [@bib0205], [@bib0245], [@bib0250]). Recovery is also increasingly associated with achieving benefits in a wide range of life areas, including housing, health, employment, offending, relationships, self-care, use of time, community participation, and general well-being ([@bib0005], [@bib0070], [@bib0180], [@bib0230]). In 2009, Laudet identified a 'critical' need for an addiction recovery measure that would capture the multi-dimensional nature of recovery and the views of multiple stakeholder groups, including service users ([@bib0115]).

Within many areas of medicine, assessment of patients' views of their own health status is considered essential for improving the quality and cost effectiveness of services and interventions ([@bib0050]). This has resulted in the development of self-completion questionnaires, rating scales and assessment forms, known as patient reported outcome measures (or PROMs). PROMs assess a patient's health status or health-related quality of life at a single point in time, give priority to the patient's − rather than the clinician's − perspective, and focus on the quality rather than just the quantity of life ([@bib0050]). This is important since professionals' assessments of patients' treatment needs and health status often differ from patients' own assessments, and patients and professionals may disagree about the relative importance of specific outcomes ([@bib0085], [@bib0190], [@bib0210], [@bib0215], [@bib0235]).

Involving members of the target patient population in generating questions for a new PROM helps to ensure that the measure developed captures all relevant concepts in a meaningful way and that the questions asked are clear and interpretable ([@bib0190], [@bib0185], [@bib0195]). Engagement of this kind is best achieved using qualitative methods such as in-depth interviews, focus groups or other open consultation processes ([@bib0105]). After development, PROMs should be subjected to rigorous psychometric testing to ensure that they are reliable, valid, and measure health status and health-related outcomes as objectively as possible ([@bib0050], [@bib0185]).

This paper reports on a study that had two aims: i. to develop a PROM for recovery from drug and alcohol dependence that has good face and content validity, acceptability and usability for people in recovery; ii. to evaluate the psychometric properties and factorial structure of the PROM using suitable statistical techniques. The PROM developed is inherently different from existing outcome tools − such as the Addiction Severity Index (ASI; [@bib0150]), Opiate Treatment Index (OTI; [@bib0045]), Maudsley Addiction Profile (MAP; [@bib0145]), Brief Treatment Outcome Measure (BTOM; [@bib0120]), Treatment Outcomes Profile (TOP; [@bib0140]), and Addiction Dimensions for Assessment and Personalised Treatment (ADAPT; [@bib0135]). It is the first tool to focus specifically on the concept of 'recovery' and the only one developed with extensive service user input. Reflecting this, it prioritises outcomes deemed important by people in recovery (rather than clinicians or others) and is intended for self-completion.

2. MATERIAL AND METHODS {#sec0010}
=======================

The study received ethical approval from the UK National Research Ethics Service (reference number: 13/LO/1584). Study aim i. (hereafter, 'item development') and study aim ii. (hereafter, 'measurement evaluation') were each undertaken in stages (see [Fig. 1](#fig0005){ref-type="fig"}).

2.1. Item development {#sec0015}
---------------------

Item development occurred between October, 2013 and January, 2015. The demographic characteristics of the individuals who participated in the various item development stages (25 service providers and 109 service users) are presented in Tables S1-S4 in the supplementary materials. Participating service users were recruited from across London, UK, and received a £15 voucher in compensation for their time; participating service providers received no financial compensation. Throughout the development process, the research team also received support and advice from a separate project advisory group comprising 11 addiction service users who were each paid £20 per consultation.

### 2.1.1. Stage 1 {#sec0020}

UK-based addiction psychiatrists, senior residential rehabilitation staff and senior inpatient detoxification staff (N = 25) were asked to identify indicators of recovery in online Delphi groups ([@bib0170]). This had originally been intended as a separate study but the indicators identified were so wide-ranging that they provided a useful starting point for stage 2. At all subsequent developmental stages, service users were encouraged to add new indicators.

### 2.1.2. Stage 2 {#sec0025}

Indicators of recovery identified by the 25 service providers and the meaning of recovery more broadly were discussed within 5 focus groups of current and former drug and alcohol service users (N = 44 service users in total) ([@bib0190]). The research team discarded indicators that the focus group participants described as irrelevant, inappropriate or offensive and reworded indicators that group participants had deemed unacceptable due to terminology or language. The reworded indicators were combined with indicators that group participants had generally agreed were acceptable.

### 2.1.3. Stage 3 {#sec0030}

Members of the research team turned the revised recovery indicators into recovery statements (candidate PROM items)

### 2.1.4. Stage 4 {#sec0035}

Two further focus groups of current and former service users debated and ranked the candidate PROM items, focusing on wording, acceptability and importance. The research team then analysed the focus group discussions to produce a draft measure, which was discussed with members of the project advisory group.

### 2.1.5. Stage 5 {#sec0040}

A new sample of 18 current and former service users completed the draft measure in person, commenting on wording, content and form. The research team used the service user feedback to generate a beta version of the measure, again in consultation with the project advisory group.

### 2.1.6. Stage 6 {#sec0045}

A further 30 current and former services users completed the beta version of the measure in person, commenting on the appropriateness and usefulness of the items, scaling system, and layout. The research team analysed all feedback.

2.2. Measurement evaluation sample {#sec0050}
----------------------------------

Data collection for the measurement evaluation occurred between February, 2015 and June, 2015.

### 2.2.1. In Person (IP) sample {#sec0055}

Current and former service users (N = 461) were recruited from community-based clinical services, third sector services, and peer support services across London (n = 329), Birmingham (n = 100) and West Sussex (n = 32), UK. These individuals completed a questionnaire that comprised basic demographic, drug use and recovery questions and the recovery measure. Participants were offered refreshments to compensate for their time.

The first 111 (London-based) participants additionally completed two validated measures: i. the WHOQOL-BREF − a quality of life assessment ([@bib0225]), and ii. the ARC − a scale that assesses addiction recovery capital ([@bib0065]). Of these 111 individuals, the first 50 completed the questionnaire and validated measures a second time, 2--7 days later. These 111 individuals received a £10 supermarket voucher for each questionnaire completed.

### 2.2.2. Online (OL) sample {#sec0060}

To expand the geographical reach of the data collection, an online version of the demographic, drug use and recovery questions and the recovery measure was created using the survey tool BOS ([https://www.onlinesurveys.ac.uk/](http://https://www.onlinesurveys.ac.uk/){#intr0005}). The survey link was emailed to 14 recovery-focused organisations based across England and Scotland. No attempt was made to promote the survey more widely and no compensation was offered for completing the survey. In total, 114 individuals responded online from across the UK.

The descriptive indices of the IP and OL samples are presented and compared in [Table 1](#tbl0005){ref-type="table"}.

2.3. Statistical analyses {#sec0065}
-------------------------

The latent structure of the new measure was assessed via factor analysis for categorical data using the weighted least squares estimator (WLSMV; [@bib0160]). The IP sample was randomly divided into split half samples; the first sub-sample was used in exploratory factor analysis (EFA) and the second one in confirmatory factor analysis (CFA) for categorical data. Both measures of absolute and relative fit were assessed, namely the relative chi-square (relative χ^2^: values close to 2 indicate close fit; [@bib0075]), the Root Mean Square Error of Approximation (RMSEA, values less than 0.8 are required for adequate fit; [@bib0020]), the Taylor-Lewis Index (TLI, values higher than 0.9 are required for close fit; [@bib0015]) and the Comparative Fit Index (CFI, values higher than 0.9 are required for close fit; [@bib0010]).

The adequacy of the rating scale was evaluated according to the recommendations described by [@bib0125], both within each factor and for the complete set of items. Any item differential functioning (DIF) with respect to the data source (IP vs OL) and gender was assessed using multiple indicator multiple cause (MIMIC) structural equation models ([@bib0155]).

The reliability of the scale in terms of internal consistency was evaluated using [@bib0040] alpha coefficient. In terms of stability, test-retest reliability was assessed at item level using [@bib0035] weighted Kappa coefficient (κ) and at score level using the intraclass correlation coefficient (ICC; [@bib0095]).

Concurrent convergent validity was evaluated via correlations with the WHOQOL-BREF and ARC subscale scores (Pearson's r). Discriminative validity was assessed via score differences between participant sub-groups based on their responses to demographic, drug use and recovery questions in the questionnaire (t-test for 2 groups; one-way ANOVA for 3 or more groups).

Data analyses were conducted using R ([@bib0200]), Facets ([@bib0130]), and Mplus ([@bib0165]) statistical packages.

3. RESULTS {#sec0070}
==========

3.1. Item development outcome {#sec0075}
-----------------------------

In *Stage 1*, the online Delphi groups with service providers generated 76 indicators of recovery that comprised 15 broad domains (Table S5; [@bib0170]). The *Stage 2* focus group participants identified multiple problems with the 76 indicators, suggesting that many were irrelevant, inappropriate, contradictory or offensive ([@bib0190]). Indicators were discarded, reworded or accepted accordingly, generating a new set of 33 recovery indicators. In *Stage 3,* the 33 recovery indicators were turned into 33 recovery statements (candidate items) by members of the research team (Table S6). Analyses from the two *Stage 4* service user focus groups resulted in further rewording of items, deletion of items and the inclusion of some new items. This generated a draft recovery measure comprising 30 items (Table S7).

*In Stage 5,* the researchers used feedback from the next sample of 18 current and former service users to amend the items again, so generating a beta version of the measure (30 items across 8 domains) (Table S8). Each of the 30 items utilized a five-point, ordinal (polytomous) rating scale, with scores ranging from 0-4, except for the first four items which were reversed scored (total score range 0-120). An additional 8 questions at the end of the measure were not scored, but allowed individuals to rank each domain on a four-point Likert scale for its importance to them personally.

In the final development stage *(Stage 6),* 30 individuals completed the beta version recovery measure. In total, 29 (97%) reported the measure was easy to complete, 28 (93%) reported it was easy to understand, 25 (83%) reported the length was about right, and 21 (70%) reported that it covered everything important. Items that individuals identified as missing from the measure were reviewed, but all had already been considered within the earlier developmental stages and so were discounted. Time to complete the measure ranged from 4--15 minutes. Fourteen individuals (47%) volunteered that they had enjoyed completing it and none stated that they had disliked completing it. All of the domains were consistently ranked as 'important' or 'very important' by at least 28 (93%) participants. Good face and content validity, acceptability and usability for people in recovery were confirmed.

3.2. Measurement evaluation {#sec0080}
---------------------------

### 3.2.1. Item refinement {#sec0085}

Using the 5-point (0-4) rating scale, Cohen's weighted κ coefficient was \< 0.4 for 2 of the 30 items ('I have abused medication prescribed to me by a doctor' and 'I have had enough company and spent enough time with other people'). These two items were therefore omitted from the measure on the grounds of low stability ([@bib0100]). This resulted in a shortened 28-item recovery measure that was used for the rating scale evaluation.

Following [@bib0125], we first considered whether adjacent categories in the rating scale needed to be combined. As Rasch analysis assumes unidimensionality, an initial exploratory factor model was fitted and this indicated five factors. Analyses of each of the five factors and of the complete scale revealed that two pairs of categories ("0-1" and "3-4") should be merged. This is illustrated in [Fig. 2](#fig0010){ref-type="fig"} which shows that, when five categories were used, the probability of responding "0" was higher than the probability of responding "1" at the lower end of the latent trait even when category "1" reached its peak. That is, at the point on the latent continuum where category "1" occurred more often than at any other point, participants were still more likely to choose "0", making the distinction between the two response options redundant. Similarly, the probability of responding "4" was always higher than the probability of responding "3" at the higher end of the latent trait. This phenomenon is usually referred to as *distorted thresholds* (see [@bib0125] for details). In contrast, when a 3-point (1-3) rating scale was used, there was a natural transition on the ordered categories in terms of the amount of the latent trait (x-axis) and the probability of choosing each category (y-axis).

The preliminary results were also used to omit items that: i. showed low loadings across all factors; ii. reduced the alpha coefficient of the total scale or within a factor (low construct validity); or iii. had very high loadings in multiple factors (high complexity) (Table S9). These additional omissions produced a final 21-item measure. Service users in the project advisory group confirmed that the 21-item measure retained good face and content validity, helped identify a name for the new measure, and facilitated wider face-to-face and online consultation with service users to confirm the name: 'Substance Use Recovery Evaluator' or 'SURE'. Full psychometric assessment (reported below) was therefore undertaken using the final 21-item measure and a 3-point (1-3) rating scale.

### 3.2.2. Full assessment of psychometric properties {#sec0090}

#### 3.2.2.1. Factor structure {#sec0095}

Exploratory factor analysis for categorical items was performed using a random half of the IP sample (N = 231). The first five eigenvalues were 9.6, 1.9, 1.5, 1.2, and 1.0. The five-factor solution demonstrated close fit to the data with RMSEA = 0.046, relative χ^2^ = 1.5 and RMSR = 0.041. Increasing the number of factors resulted in similar fit indices so, consistent with the parsimony axiom, the five-factor solution was accepted. [Table 2](#tbl0010){ref-type="table"} shows the loadings of the items on the factors (Promax rotation), according to which the underlying dimensions were named: "substance use" (SU), "material resources" (MR), "outlook on life" (OK), "self-care" (SC), and "relationships" (RE).

Confirmatory factor analysis for categorical items was next performed using the second random half of the IP sample (N = 230). The first model implemented used the one factor solution to check that the scale was not unidimensional. As anticipated, the one factor solution did not show close fit to the data (relative χ^2^ = 3.2, with RMSEA = 0.098, TLI = 0.91, CFI = 0.92). In contrast, the EFA suggested solution did demonstrate close fit to the data (relative χ^2^ = 1.7, with RMSEA = 0.055, TLI = 0.97, CFI = 0.98). Thus, the 5-factor solution suggested by the EFA was confirmed by the CFA (CFA loadings are presented in [Table 2](#tbl0010){ref-type="table"}). The five-factor model also had close fit in the OL sample (RMSEA = 0.055, relative χ^2^ = 1.3, TLI = 0.99, CFI = 0.99).

#### 3.2.2.2. Differential item functioning {#sec0100}

The next step in the analysis was to test whether the model was invariant across the two samples: IP and OL. The fit of the MIMIC model was adequate (relative χ^2^ = 2.8, RMSEA = 0.057, TLI = 0.97, CFI = 0.98). Only one direct effect was significant: individuals who completed the questionnaire OL had increased probability of scoring higher in "managed pains and ill health" than individuals who completed IP for the same levels of recovery (effect = 0.536, se = 0.2, p = 0.014). These results indicated metric invariance across the two groups for 95% of the items. For the DIF assessment of gender, the complete sample (IP and OL) was used. With respect to gender, none of the direct effects was significant (100% metric invariance, relative χ^2^ = 2.7, RMSEA = 0.055, TLI = 0.98, CFI = 0.98).

#### 3.2.2.3. Descriptive indices and associations with sample characteristics {#sec0105}

The descriptive indices for the five factors by gender and total score (TS) are presented in [Table 3](#tbl0015){ref-type="table"}. Females, scored higher than males in the SU and MR factors. In terms of differences between the IP and OL samples, the OL sample scored significantly higher in all factors (p \< 0.001 in all cases), adding up to a mean difference of 8 units (s.e.=0.91) for the total score (t = 8.59, df = 573, p \< 0.01). The inter-correlations across the factors and total score were positive, significant and moderate to strong ([Table 4](#tbl0020){ref-type="table"}). Age correlated weakly with the SU and MR factors as well as with the total score, indicating that individuals tended to have higher scores as age increased.

3.3. Reliability {#sec0110}
----------------

Cronbach's alpha coefficient was high in the IP sample (alpha = 0.91), the OL sample (0.93) and when all individuals were considered together (0.92), so indicating high internal consistency of the items. No problematic items were found in terms of internal consistency or low item-total correlations. The reliability coefficients were also satisfactory at factor level, albeit lower than for the total questionnaire due to the small number of items in each factor ([Table 3](#tbl0015){ref-type="table"}).

When the test-retest analyses were repeated using the 3-point (1-3) rating scale, Cohen's weighted κ coefficient for all 21 items varied from 0.4 to 0.8, representing 'moderate to substantial agreement' according to [@bib0100]. The ICC was 0.9 for the total score and 0.6-0.8 for the five factors (Table S9). Additionally, no significant mean differences were found between the scores of the factors or the total score, meaning that test-retest reliability was granted for the final 21-item measure (Table S10).

### 3.3.1. Validity {#sec0115}

The correlations presented in [Table 5](#tbl0025){ref-type="table"} confirm that the 5 factors of the new recovery measure correlated positively with the WHOQOL-BREF and the ARC subscale scores, demonstrating appropriate concurrent convergent validity. Moreover, the highest coefficients emerged when the content of the scales were matching.

In testing for discriminative validity, we found that people who reported that they had been in paid work in the last month had a significantly higher total score on the 21-item recovery measure than those who said that they had not been in paid work ('in paid work': mean = 45.9, sd = 9.6; 'not in paid work': mean = 42.1; sd = 9.2, t = 3.70, df = 571, p \< 0.001). People who reported that they had been homeless in the last month had a lower total recovery score than those who reported that they had not been homeless ('homeless': mean = 36.5, sd = 8.3; 'not homeless': mean = 43.7, sd = 9.2; t = −6.19, df = 572, p \< 0.001). Additionally, people who reported that had been in prison in the last month had a lower total recovery score than those who reported that they had not been in prison ('in prison': mean = 35.9, sd = 6.4; 'not in prison': mean = 43.5, sd = 9.3; t = −2.68, df = 460, p = 0.008).

We also found significant differences in mean total recovery scores based on whether or not participants self-reported use of any drugs or alcohol in the last year. Specifically, one way ANOVA indicated that the total recovery score was significantly higher (F\[3,568\] = 45.7, p \< 0.001) for individuals who reported that they had not used any substances (drugs or alcohol) (mean = 52.0, sd = 6.7, N = 77), than for individuals reporting alcohol use only (mean = 44.3, sd = 9.6, N = 151), individuals reporting drug use only (mean = 40.3, sd = 8.3, N = 228), and individuals reporting both drug and alcohol use (mean = 39.23, sd = 8.2, N = 116). According to the Bonferroni adjustment for multiple comparisons, all pairwise mean differences were significant (p \< 0.001 in all cases).

In terms of participants' self-evaluation of their recovery status (i.e., whether or not they currently considered themselves to be 'in recovery'), one way ANOVA indicated that individuals who reported that they were currently 'in recovery' scored significantly higher (mean = 45.2, sd = 9.1, N = 350) than those who replied negatively (mean = 38.1, sd = 8.2, N = 59) and those who were unsure (mean = 37.3, sd = 7.3, N = 55; F\[2,461\] = 30.70, p \< 0.001). According to the Bonferroni adjustment for multiple comparisons, all pairwise mean differences were again significant (p \< 0.001 in all cases).

4. DISCUSSION {#sec0120}
=============

Extensive developmental work, comprising qualitative and quantitative methods, with significant input from service users, was undertaken to develop items for 'SURE', a new PROM for recovery from drug and alcohol dependence. The final measure comprises 21 items and 5 factors: "substance use" (6 items), "material resources" (3 items), "outlook on life" (3 items), "self-care" (5 items) and "relationships" (4 items). Members of a service user project advisory group confirmed face and content validity and service users helped to determine the name of the new measure. Analyses established the measure's factor structure, invariance, reliability and validity. SURE is distinct from other addiction outcome measures given its focus on 'recovery', and overall prioritisation of the service user perspective in both its development and intended use.

The five factors identified are consistent with a concept of recovery that encompasses a range of life areas ([@bib0005], [@bib0070], [@bib0180], [@bib0230]). Only 6/21 items explicitly refer to substance use, highlighting how it is possible to be in 'recovery', despite some drinking or drug taking. This reflects the more inclusive (non-abstinence) approach to recovery that has gained traction in recent years ([@bib0060]; Recovery Orientated Drug Treatment Expert Group, 2012). That there is no standalone employment item is also notable given the UK Government's repeated emphasis on drug users having to secure paid work ([@bib0055], [@bib0080], [@bib0230]). Instead, 'SURE' has an item that refers to 'having a regular income (from benefits, work or other legal sources)', and a related item on 'having a good daily routine'. These alternative indicators implicitly acknowledge that individuals may not be able to secure paid work for structural reasons unrelated to personal recovery (e.g., lack of jobs or employers' lack of willingness to employ people with a history of substance use or related criminal activity) ([@bib0090]) and that stability and having meaningful activity are more valid indicators of recovery.

Each of the five factors is internally coherent. For example, the 6 substance use items are the only items that explicitly refer to drinking or drug use and the four relationship items are the only four that explicitly relate to 'people'. The only factor that did not correlate significantly with the WHOQOL-BREF and the ARC was 'material resources'. This warrants consideration. Previous qualitative research ([@bib0180], [@bib0175]) and the focus groups we conducted in developing the measure ([@bib0190]) have found that people in recovery want stable housing, regular income and money to pay bills. However, they do not generally covet material good or wealth because i. disposable income can become a temptation to buy drugs or alcohol and ii. they tend to prioritise relationships and people over possessions. This may help to explain why our 3 material resource items correlated well with recovery in general, but less well with substance use, and other general quality of life indicators.

'SURE' items are completed using a 5-point rating scale, but scored using a 3-point scale (the two categories at the lower end of the latent trait are combined, as are the two categories at the higher end of the latent trait). Total 'SURE' scores therefore range from 21-63. The 5-point scale has been retained for completion purposes because: i. service users repeatedly told us that they liked having five options to consider; ii. it is not difficult to re-score the items post completion; and iii. we noticed that service users completing the measure often paused thoughtfully when deciding how to respond to the five categories, and then spontaneously discussed their thoughts with the researcher. As we have previously argued ([@bib0185]), completion of the PROM seldom simply generated a numeric score. Rather, it prompted people to reflect on and volunteer potentially valuable contextual information about their lives and circumstances that might be relevant in a therapeutic context.

As with all new measures, there are limitations. First, we note that 'SURE' is not tailored for use in residential settings (e.g., residential detoxification, residential rehabilitation or prison). Although we included residential treatment clients in our developmental work to ensure that their views were captured, service user feedback indicated that several items were difficult for residential clients to answer. This is because responses to items such as 'eaten a good diet', 'having stable housing', 'having a good daily routine,' and 'managing money' tend to be affected by the structure and routine of the residential setting and so beyond individual control. Service users living in residential settings were therefore not included in the sample used for the measurement evaluation. Second, additional validity testing (e.g., criterion or predictive validity) would be desirable. Third, language and terminology are historically and culturally sensitive. The wording of items in 'SURE' (particularly those relating to substance use) need to be carefully reviewed to find culturally appropriate terms if the measure is to be used in other countries.

In contrast, 'SURE' has a number of significant strengths. First, service users have played a fundamental role in its design and content, and it is found to have good face validity. This level of service user engagement is unprecedented in any existing validated addiction outcome measure. Second, the measure has been designed by a careful and considered blending of qualitative methods (with their focus on subjective meaning and understanding) and more objective quantitative techniques. This capitalises on the strengths of each to ensure a robust development and validation process. Third, the study participants were diverse in terms of age, ethnicity, drugs used, and geographical location, thus providing reassurances in terms of inclusion and diversity. Fourth, the measure retains five unscored questions at the end that encourage participants to reflect on how important each of the factors is to them personally. Service users liked this final component. As a member of the advisory group explained: "I like the way that it ends... this part reinforces that the service user has a big part to play; that this is what's important to them as individuals".

'SURE' is a psychometrically valid, quick and easy-to-complete measure, developed with significant input from people in recovery. It can be used by individuals to monitor and reflect on their own recovery journeys, either in private or in the context of a therapeutic relationship. It can also be used to assess treatment outcomes at a service level or by researchers seeking to evaluate new interventions. As such it can be used either alongside, or instead of, existing outcome tools. In the coming months we will continue our work by exploring opportunities for developing online and app versions with an integrated scoring system and graphical displays; collecting longitudinal data to test for predictive validity; seeking collaborators for international validation; and adapting the methodology for other drug and alcohol related PROMs, PREMs (Patient Reported Experience Measures) and CROMs (Carer Reported Outcome Measures).
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###### 

Descriptive indices by sample (in person vs online) and comparison.

Table 1

                                                            *In person*   *Online*      *Comparison*              
  --------------------------------------------------------- ------------- ------------- -------------- ---------- ---------------
  Gender                                                                                                          
  *Males*                                                   333 (86%)     54 (14%)      ***χ^2^***     ***df***   ***p-value***
  *Females*                                                 128 (68%)     60 (32%)      25.68          1          \<0.001
  Age                                                                                                             
  *Mean*                                                    43.0          44.7          ***t***        ***df***   ***p-value***
  *SD*                                                      10.0          9.1           −1.680         572        0.093
  Ethnicity                                                                                                       
  *White*                                                   362 (76.4%)   112 (23.6%)   ***χ^2^***     ***df***   ***p-value***
  *Other*                                                   99 (98%)      2 (2%)        24.55          1          \<0.001
  Last month                                                                                                      
  *Main substance used: None*                               39 (9%)       38 (34%)      ***χ^2^***     ***df***   ***p-value***
  *Drugs*                                                   113 (25%)     38 (34%)      67.56          3          \<0.001
  *Alcohol*                                                 209 (45%)     19 (17%)                                
  *Both*                                                    100 (22%)     16 (14%)                                
                                                                                                                  
  *In recovery (self-rated): No*                            54 (16%)      5 (4%)        ***χ^2^***     ***df***   ***p-value***
  *Yes*                                                     253 (72%)     97 (85%)      10.34          2          \<0.001
                                                                                                                  
  *Homeless: No*                                            394 (90%)     110 (100%)    ***χ^2^***     ***df***   ***p-value***
  *Yes*                                                     67 (10%)      3 (0%)        11.96          1          0.001
                                                                                                                  
  *In paid legal work*: *No*                                406 (90%)     67 (60%)      ***χ^2^***     ***df***   ***p-value***
  *Yes*                                                     55 (10%)      45 (40%)      49.91          1          \<0.001
                                                                                                                  
  *In residential treatment: No*                            317 (90%)     110 (100%)    ***χ^2^***     ***df***   ***p-value***
  *Yes*                                                     33 (10%)      3 (0%)        5.47           1          0.019
                                                                                                                  
  *In prison: No*                                           339 (100%)    112 (100%)    ***χ^2^***     ***df***   ***p-value***
  *Yes*                                                     11 (0%)       0 (0%)        3.61           1          0.058
                                                                                                                  
  *Prescribed OPT*^a^*: No*                                 253 (50%)     104 (90%)     ***χ^2^***     ***df***   ***p-value***
  *Yes*                                                     208 (50%)     10 (10%)      51.90          1          0.001
                                                                                                                  
  *Prescribed medication for alcohol dependence*^b^*: No*   331 (90%)     103 (90%)     ***χ^2^***     ***df***   ***p-value***
  *Yes*                                                     18 (10%)      10 (10%)      2.04           1          0.153
  Lifetime:                                                                                                       
  *Injected drug*: *No*                                     300 (70%)     78 (70%)      ***χ^2^***     ***df***   ***p-value***
  *Yes*                                                     160 (30%)     36 (30%)      0.42           1          0.518
                                                                                                                  
  *Attendance at mutual aid or support groups: No*          216 (60%)     50 (40%)      ***χ^2^***     ***df***   ***p-value***
  *Yes*                                                     134 (40%)     63 (60%)      10.66          1          0.001

*^a^*Refers to opioid pharmacotherapy treatment: e.g., methadone, burprenorphine/Subutex, Suboxone, morphine sulphate or diamorphine*.*

*^b^*Refers to: acamprosate or naltrexone*.*

###### 

EFA loadings (Promax rotation) for the first random half of the IP sample (N = 231) and CFA loadings (in parentheses) for the second random half of the IP sample (N = 230).[a](#tblfn0005){ref-type="table-fn"}

Table 2

  No   Item                                                      Substance Use (SU)   Material Resources (MR)   Outlook on Life (OK)   Self-care (SC)   Relationships (RE)
  ---- --------------------------------------------------------- -------------------- ------------------------- ---------------------- ---------------- --------------------
  1    Drunk too much                                            0.79 (1.00)                                                           −0.30            
  2    Used street drugs                                         0.52 (1.13)                                                                            
  3    Had cravings                                              0.44 (1.16)                                                                            
  5    Coped with problems[b](#tblfn0010){ref-type="table-fn"}   0.93 (1.58)                                                                            
  7    Managed pains and ill health^b^                           0.77 (1.70)                                                                            
  16   Had non drug hobbies and interests                        0.59 (1.78)                                                                            
  12   Had stable housing                                                             0.62 (1.00)                                                       
  13   Had a regular income                                                           0.87 (1.02)                                                       
  14   Been managing money                                                            0.57 (0.91)                                                       
  17   Felt happy with quality of life                                                                          0.90 (1.00)                             
  18   Felt positive                                                                                            0.94 (1.02)                             
  19   Had realistic hopes and goals                                                                            0.66 (0.91)                             
  4    Looked after mental health                                                                                                      0.48 (1.00)      
  6    Looked after physical health                                                                                                    0.66 (1.41)      
  8    Eaten a good diet                                                                                                               0.95 (1.18)      
  9    Slept well                                                                                                                      0.44 (1.10)      
  15   Had a good daily routine                                                                                 0.31                   0.42 (1.44)      
  10   Got on well with people                                                                                                                          0.45 (1.00)
  11   Felt supported by people                                                                                 0.40                                    0.43 (1.08)
  20   Been treated with respect                                                                                                                        0.82 (1.10)
  21   Treated others with respect                                                                                                                      0.57 (0.75)

All loadings presented were significant (p \< 0.05).

Without drugs or alcohol.

###### 

Cronbach's alpha coefficient and score differences by gender.

Table 3

                                           a      Females           Males           Complete Sample   Comparison                                  
  ---------------------------------------- ------ ----------------- --------------- ----------------- --------------- ----------- --------------- --------------------------------------------------------------
  SU                                       0.83   **13.5** (14)     *3.6 (6-18)*    **12.7** (12)     *3.5 (6-18)*    13 (13)     *3.6 (6-18)*    **t** **=** **2.57, df** **=** **573, p** **=** **0.010**
  **SC**                                   0.82   9.2 (9)           *2.9 (5-15)*    9.1 (9)           *2.6 (5-15)*    9.1 (9)     *2.7 (5-15)*    t = 0.75, df = 573, p = 0.451
  OK                                       0.87   5.1 (5)           *1.8 (3-9)*     5.3 (6)           *1.8 (3-9)*     5.2 (6)     *1.8 (3-9)*     t = −1.19, df = 573, p = 0.235
  **RE**                                   0.74   8.6 (8)           *2.0 (4-12)*    8.5 (8)           *1.9 (4-12)*    8.5 (8)     *1.9 (4-12)*    t = 0.37, df = 573, p = 0.715
  MR                                       0.68   **7.5** (8)       *1.5 (3-9)*     **6.7** (7)       *1.8 (3-9)*     7 (7)       *1.7 (3-9)*     **t** **=** **5.27, df** **=** **430\*, p** **\<** **0.001**
  TS[a](#tblfn0015){ref-type="table-fn"}   0.92   **43.9** (44.5)   *9.6 (24-63)*   **42.3** (42)     *9.3 (22-63)*   42.8 (43)   *9.4 (22-63)*   t = 1.93, df = 573, p = 0.054

*^\*^*equal variances not assumed*.*

Total Score.

###### 

Factor, total score and age inter-correlations.

Table 4

        SU                  SC                  OK                  RE                  MR                  TS
  ----- ------------------- ------------------- ------------------- ------------------- ------------------- -----------------
  SC    **0.6** (\<0.001)                                                                                   
  OK    **0.5** (\<0.001)   **0.7** (\<0.001)                                                               
  RE    **0.5** (\<0.001)   **0.6** (\<0.001)   **0.6** (\<0.001)                                           
  MR    **0.5** (\<0.001)   **0.5** (\<0.001)   **0.4** (\<0.001)   **0.5** (\<0.001)                       
  TS    **0.8** (\<0.001)   **0.9** (\<0.001)   **0.8** (\<0.001)   **0.8** (\<0.001)   **0.7** (\<0.001)   
  Age   **0.2** (\<0.001)   0.1 (0.098)         \<0.1 (0.478)       0.1 (0.074)         **0.2** (\<0.001)   **0.1 (0.003)**

###### 

Correlation coefficients for the recovery measure scores and subscale scores of the WHOQOL-BREF and the ARC.[a](#tblfn0020){ref-type="table-fn"}

Table 5

  --------------
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Grey values correspond to non-significant correlations after adjusting for multiple comparisons (p-value within parenthesis); for the remaining coefficients, the p-value was \<0.001.
